Clinical Trial Update: Kogenate FS Regulatory Post-Marketing Surveillance

View source ↗

Summary

A post-marketing surveillance trial for Bayer's Kogenate FS focusing on Hemophilia A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Kogenate FS (Factor VIII)

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Status: COMPLETED